Overview
Kiyohiro Ando practices in Saitama, Japan. Ando is rated as an Advanced expert by MediFind in the treatment of Neuroblastoma. Their top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Congenital Aplastic Anemia.
Their clinical research consists of co-authoring 28 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 11 articles in the study of Neuroblastoma.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Embryonal Tumor with Multilayered Rosettes
- Gliomatosis CerebriAndo isAdvanced. Learn about Gliomatosis Cerebri.
- NeuroblastomaAndo isAdvanced. Learn about Neuroblastoma.
- Experienced
- AnemiaAndo isExperienced. Learn about Anemia.
- Aplastic AnemiaAndo isExperienced. Learn about Aplastic Anemia.
- Bladder CancerAndo isExperienced. Learn about Bladder Cancer.
- Congenital Aplastic AnemiaAndo isExperienced. Learn about Congenital Aplastic Anemia.
- Fanconi AnemiaAndo isExperienced. Learn about Fanconi Anemia.
- Pancreatic CancerAndo isExperienced. Learn about Pancreatic Cancer.